Peginterferon-lambda shows strong antiviral action to accelerate clearance of COVID-19
China approves second domestic COVID-19 vaccine
6 February 2021Yankees stadium becomes vaccination site for New York’s poor
6 February 2021Peginterferon-lambda shows strong antiviral action to accelerate clearance of COVID-19
A clinical study led by Dr. Jordan Feld, a liver specialist at Toronto Centre for Liver Disease, University Health Network (UHN), showed an experimental antiviral drug can significantly speed up recovery for COVID-19 outpatients—patients who do not need to be hospitalized.
